TY - STD TI - International Restless Legs Syndrome Study Group - Diagnostic Criteria. Available from: http://www.irlssg.org/Diagnostic-Criteria. [cited 2020 Sep 22] UR - http://www.irlssg.org/Diagnostic-Criteria ID - ref1 ER - TY - JOUR AU - Yeh, P. AU - Walters, A. S. AU - Tsuang, J. W. PY - 2012 DA - 2012// TI - Restless legs syndrome: A comprehensive overview on its epidemiology, risk factors, and treatment JO - Sleep Breath VL - 16 UR - https://doi.org/10.1007/s11325-011-0606-x DO - 10.1007/s11325-011-0606-x ID - Yeh2012 ER - TY - JOUR AU - Liu, G. J. AU - Wu, L. AU - Wang, S. L. AU - Ding, L. AU - Xu, L. L. AU - Wang, Y. F. PY - 2016 DA - 2016// TI - Incidence of Augmentation in Primary Restless Legs Syndrome Patients May Not Be That High JO - Medicine (Baltimore) VL - 95 UR - https://doi.org/10.1097/MD.0000000000002504 DO - 10.1097/MD.0000000000002504 ID - Liu2016 ER - TY - JOUR AU - Ohayon, M. M. AU - O’Hara, R. AU - Vitiello, M. V. PY - 2012 DA - 2012// TI - Epidemiology of restless legs syndrome: A synthesis of the literature JO - Sleep Med Rev VL - 16 UR - https://doi.org/10.1016/j.smrv.2011.05.002 DO - 10.1016/j.smrv.2011.05.002 ID - Ohayon2012 ER - TY - JOUR AU - Guo, S. AU - Huang, J. AU - Jiang, H. AU - Han, C. AU - Li, J. AU - Xu, X. PY - 2017 DA - 2017// TI - Restless legs syndrome: From pathophysiology to clinical diagnosis and management JO - Front Aging Neurosci VL - 9 UR - https://doi.org/10.3389/fnagi.2017.00171 DO - 10.3389/fnagi.2017.00171 ID - Guo2017 ER - TY - JOUR AU - Ruppert, E. PY - 2019 DA - 2019// TI - Restless arms syndrome: Prevalence, impact, and management strategies JO - Neuropsychiatr Dis Treat VL - 15 UR - https://doi.org/10.2147/NDT.S161583 DO - 10.2147/NDT.S161583 ID - Ruppert2019 ER - TY - JOUR AU - Horiguchi, J. AU - Hornyak, M. AU - Voderholzer, U. AU - Kryger, M. AU - Skomrow, R. AU - Lipinski, J. F. PY - 2003 DA - 2003// TI - Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome JO - Sleep Med VL - 4 UR - https://doi.org/10.1016/S1389-9457(02)00258-7 DO - 10.1016/S1389-9457(02)00258-7 ID - Horiguchi2003 ER - TY - JOUR AU - Winkelmann, J. AU - Schormair, B. AU - Lichtner, P. AU - Ripke, S. AU - Xiong, L. AU - Jalilzadeh, S. PY - 2007 DA - 2007// TI - Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions JO - Nat Genet VL - 39 UR - https://doi.org/10.1038/ng2099 DO - 10.1038/ng2099 ID - Winkelmann2007 ER - TY - JOUR AU - Peeraully, T. AU - Tan, E. K. PY - 2012 DA - 2012// TI - Linking restless legs syndrome with Parkinson’s disease: clinical, imaging and genetic evidence JO - Transl Neurodegener VL - 1 UR - https://doi.org/10.1186/2047-9158-1-6 DO - 10.1186/2047-9158-1-6 ID - Peeraully2012 ER - TY - JOUR AU - Allen, R. P. PY - 2015 DA - 2015// TI - Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology JO - Sleep Med Clin VL - 10 UR - https://doi.org/10.1016/j.jsmc.2015.05.022 DO - 10.1016/j.jsmc.2015.05.022 ID - Allen2015 ER - TY - JOUR AU - Patatanian, E. AU - Claborn, M. K. PY - 2018 DA - 2018// TI - Drug-Induced Restless Legs Syndrome JO - Ann Pharmacother VL - 52 UR - https://doi.org/10.1177/1060028018760296 DO - 10.1177/1060028018760296 ID - Patatanian2018 ER - TY - JOUR AU - Garcia-Borreguero, D. AU - Silber, M. H. AU - Winkelman, J. W. AU - Högl, B. AU - Bainbridge, J. AU - Buchfuhrer, M. AU - Hadjigeorgiou, G. AU - Inoue, Y. AU - Manconi, M. AU - Oertel, W. AU - Ondo, W. AU - Winkelmann, J. AU - Allen, R. P. PY - 2016 DA - 2016// TI - Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation JO - Sleep Med VL - 21 UR - https://doi.org/10.1016/j.sleep.2016.01.017 DO - 10.1016/j.sleep.2016.01.017 ID - Garcia-Borreguero2016 ER - TY - JOUR AU - Naranjo, C. A. AU - Busto, U. AU - Sellers, E. M. AU - Sandor, P. AU - Ruiz, I. AU - Roberts, E. A. PY - 1981 DA - 1981// TI - A method for estimating the probability of adverse drug reactions JO - Clin Pharmacol Ther VL - 30 UR - https://doi.org/10.1038/clpt.1981.154 DO - 10.1038/clpt.1981.154 ID - Naranjo1981 ER - TY - JOUR AU - Guardiola-Lemaitre, B. AU - Bodinat, C. AU - Delagrange, P. AU - Millan, M. J. AU - Munoz, C. AU - Mocaër, E. PY - 2014 DA - 2014// TI - Agomelatine: Mechanism of action and pharmacological profile in relation to antidepressant properties JO - Br J Pharmacol VL - 171 UR - https://doi.org/10.1111/bph.12720 DO - 10.1111/bph.12720 ID - Guardiola-Lemaitre2014 ER - TY - STD TI - Demyttenaere K. Agomelatine: A narrative review, Eur Neuropsychopharmacol; 2011. Vol. 21. p. S703–S709. Elsevier. ID - ref15 ER - TY - JOUR AU - Cipriani, A. AU - Furukawa, T. A. AU - Salanti, G. AU - Chaimani, A. AU - Atkinson, L. Z. AU - Ogawa, Y. PY - 2018 DA - 2018// TI - Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(17)32802-7 DO - 10.1016/S0140-6736(17)32802-7 ID - Cipriani2018 ER - TY - JOUR AU - Macisaac, S. E. AU - Carvalho, A. F. AU - Cha, D. S. AU - Mansur, R. B. AU - McIntyre, R. S. PY - 2014 DA - 2014// TI - The mechanism, efficacy, and tolerability profile of agomelatine JO - Expert Opin Pharmacother VL - 15 UR - https://doi.org/10.1517/14656566.2014.862233 DO - 10.1517/14656566.2014.862233 ID - Macisaac2014 ER - TY - STD TI - Annex I Summary Of Product Characteristics. European Medicines Agency. https://www.ema.europa.eu/en/documents/product-information/valdoxan-epar-product-information_en.pdf. UR - https://www.ema.europa.eu/en/documents/product-information/valdoxan-epar-product-information_en.pdf ID - ref18 ER - TY - JOUR AU - Rao, N. PY - 2007 DA - 2007// TI - The clinical pharmacokinetics of escitalopram JO - Clin Pharmacokinet VL - 46 UR - https://doi.org/10.2165/00003088-200746040-00002 DO - 10.2165/00003088-200746040-00002 ID - Rao2007 ER - TY - JOUR AU - Levitan, M. N. AU - Papelbaum, M. AU - Nardi, A. E. PY - 2015 DA - 2015// TI - Profile of agomelatine and its potential in the treatment of generalized anxiety disorder JO - Neuropsychiatr Dis Treat VL - 11 UR - https://doi.org/10.2147/NDT.S67470 DO - 10.2147/NDT.S67470 ID - Levitan2015 ER - TY - JOUR AU - Haddad, P. M. AU - Dursun, S. M. PY - 2008 DA - 2008// TI - Neurological complications of psychiatric drugs: Clinical features and management JO - Hum Psychopharmacol VL - 23 UR - https://doi.org/10.1002/hup.918 DO - 10.1002/hup.918 ID - Haddad2008 ER - TY - JOUR AU - Koliscak, L. P. AU - Makela, E. H. PY - 2009 DA - 2009// TI - Selective serotonin reuptake inhibitor-induced akathisia JO - J Am Pharm Assoc VL - 49 UR - https://doi.org/10.1331/JAPhA.2009.08083 DO - 10.1331/JAPhA.2009.08083 ID - Koliscak2009 ER - TY - JOUR AU - Volpi-Abadie, J. AU - Kaye, A. M. AU - Kaye, A. D. PY - 2013 DA - 2013// TI - Serotonin syndrome JO - Ochsner J VL - 13 ID - Volpi-Abadie2013 ER - TY - JOUR AU - Roehrs, T. A. AU - Roth, T. PY - 2016 DA - 2016// TI - Gender differences in the efficacy and safety of chronic nightly zolpidem JO - J Clin Sleep Med VL - 12 UR - https://doi.org/10.5664/jcsm.5574 DO - 10.5664/jcsm.5574 ID - Roehrs2016 ER - TY - JOUR AU - Roehrs, T. A. AU - Randall, S. AU - Harris, E. AU - Maan, R. AU - Roth, T. PY - 2012 DA - 2012// TI - Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: A prospective placebo-controlled study JO - J Psychopharmacol VL - 26 UR - https://doi.org/10.1177/0269881111424455 DO - 10.1177/0269881111424455 ID - Roehrs2012 ER - TY - JOUR AU - Kao, C. L. AU - Huang, S. C. AU - Yang, Y. J. AU - Tsai, S. J. PY - 2004 DA - 2004// TI - A case of parenteral zolpidem dependence with opioid-like withdrawal symptoms JO - J Clin Psychiatry VL - 65 UR - https://doi.org/10.4088/JCP.v65n0918g DO - 10.4088/JCP.v65n0918g ID - Kao2004 ER - TY - JOUR AU - Wang, L. J. AU - Ree, S. C. AU - Chu, C. L. AU - Juang, Y. Y. PY - 2011 DA - 2011// TI - Zolpidem dependence and withdrawal seizure - report of two cases JO - Psychiatr Danub VL - 23 ID - Wang2011 ER - TY - JOUR AU - Gericke, C. A. AU - Ludolph, A. C. PY - 1994 DA - 1994// TI - Chronic Abuse of Zolpidem JO - JAMA VL - 272 UR - https://doi.org/10.1001/jama.1994.03520220015010 DO - 10.1001/jama.1994.03520220015010 ID - Gericke1994 ER - TY - JOUR AU - Cavallaro, R. AU - Grazia Regazzetti, M. AU - Covelli, G. AU - Smeraldi, E. PY - 1993 DA - 1993// TI - Tolerance and withdrawal with zolpidem JO - Lancet VL - 342 UR - https://doi.org/10.1016/0140-6736(93)91522-N DO - 10.1016/0140-6736(93)91522-N ID - Cavallaro1993 ER - TY - JOUR AU - Heydari, M. AU - Isfeedvajani, M. S. PY - 2013 DA - 2013// TI - Zolpidem dependence, abuse and withdrawal: A case report JO - J Res Med Sci VL - 18 ID - Heydari2013 ER - TY - JOUR AU - Červenka, S. AU - Pålhagen, S. E. AU - Comley, R. A. AU - Panagiotidis, G. AU - Cselényi, Z. AU - Matthews, J. C. PY - 2006 DA - 2006// TI - Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding JO - Brain VL - 129 UR - https://doi.org/10.1093/brain/awl163 DO - 10.1093/brain/awl163 ID - Červenka2006 ER - TY - JOUR AU - Chenu, F. AU - Mansari, M. AU - Blier, P. PY - 2013 DA - 2013// TI - Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain JO - Neuropsychopharmacology VL - 38 UR - https://doi.org/10.1038/npp.2012.140 DO - 10.1038/npp.2012.140 ID - Chenu2013 ER - TY - JOUR AU - Michaud, M. AU - Dumont, M. AU - Selmaoui, B. AU - Paquet, J. AU - Fantini, M. L. AU - Montplaisir, J. PY - 2004 DA - 2004// TI - Circadian Rhythm of Restless Legs Syndrome: Relationship with Biological Markers JO - Ann Neurol VL - 55 UR - https://doi.org/10.1002/ana.10843 DO - 10.1002/ana.10843 ID - Michaud2004 ER - TY - JOUR AU - Gupta, R. AU - Lahan, V. AU - Goel, D. PY - 2013 DA - 2013// TI - Prevalence of restless leg syndrome in subjects with depressive disorder JO - Indian J Psychiatry VL - 55 UR - https://doi.org/10.4103/0019-5545.105515 DO - 10.4103/0019-5545.105515 ID - Gupta2013 ER - TY - JOUR AU - Lee, H. B. AU - Hening, W. A. AU - Allen, R. P. AU - Kalaydjian, A. E. AU - Earley, C. J. AU - Eaton, W. W. PY - 2008 DA - 2008// TI - Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community JO - J Neuropsychiatr Clin Neurosci VL - 20 UR - https://doi.org/10.1176/jnp.2008.20.1.101 DO - 10.1176/jnp.2008.20.1.101 ID - Lee2008 ER - TY - JOUR AU - Driver-Dunckley, E. AU - Connor, D. AU - Hentz, J. AU - Sabbagh, M. AU - Silverberg, N. AU - Hernandez, J. PY - 2009 DA - 2009// TI - No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome JO - Mov Disord VL - 24 UR - https://doi.org/10.1002/mds.22701 DO - 10.1002/mds.22701 ID - Driver-Dunckley2009 ER - TY - JOUR AU - Belujon, P. AU - Grace, A. A. PY - 2017 DA - 2017// TI - Dopamine system dysregulation in major depressive disorders JO - Int J Neuropsychopharmacol VL - 20 UR - https://doi.org/10.1093/ijnp/pyx056 DO - 10.1093/ijnp/pyx056 ID - Belujon2017 ER - TY - JOUR AU - Revet, A. AU - Revet, A. AU - Revet, A. AU - Montastruc, F. AU - Montastruc, F. AU - Montastruc, F. PY - 2020 DA - 2020// TI - Antidepressants and movement disorders: A postmarketing study in the world pharmacovigilance database JO - BMC Psychiatry VL - 20 UR - https://doi.org/10.1186/s12888-020-02711-z DO - 10.1186/s12888-020-02711-z ID - Revet2020 ER - TY - JOUR AU - Rottach, K. G. AU - Schaner, B. M. AU - Kirch, M. H. AU - Zivotofsky, A. Z. AU - Teufel, L. M. AU - Gallwitz, T. PY - 2008 DA - 2008// TI - Restless legs syndrome as side effect of second generation antidepressants JO - J Psychiatr Res VL - 43 UR - https://doi.org/10.1016/j.jpsychires.2008.02.006 DO - 10.1016/j.jpsychires.2008.02.006 ID - Rottach2008 ER - TY - JOUR AU - Ondo, W. PY - 2018 DA - 2018// TI - Restless Legs Syndrome “Patient Odyssey” survey of disease burden on patient and spouses/partners JO - Sleep Med VL - 47 UR - https://doi.org/10.1016/j.sleep.2017.12.003 DO - 10.1016/j.sleep.2017.12.003 ID - Ondo2018 ER - TY - JOUR AU - Happe, S. AU - Reese, J. P. AU - Stiasny-Kolster, K. AU - Peglau, I. AU - Mayer, G. AU - Klotsche, J. PY - 2009 DA - 2009// TI - Assessing health-related quality of life in patients with restless legs syndrome JO - Sleep Med VL - 10 UR - https://doi.org/10.1016/j.sleep.2008.01.002 DO - 10.1016/j.sleep.2008.01.002 ID - Happe2009 ER - TY - JOUR AU - Benediktsdottir, B. AU - Janson, C. AU - Lindberg, E. AU - Arnardóttir, E. S. AU - Olafsson, I. AU - Cook, E. PY - 2010 DA - 2010// TI - Prevalence of restless legs syndrome among adults in Iceland and Sweden: Lung function, comorbidity, ferritin, biomarkers and quality of life JO - Sleep Med VL - 11 UR - https://doi.org/10.1016/j.sleep.2010.08.006 DO - 10.1016/j.sleep.2010.08.006 ID - Benediktsdottir2010 ER -